Reductio ad absurdum in critical care trials
- PMID: 33096348
- DOI: 10.1016/j.jcrc.2020.10.001
Reductio ad absurdum in critical care trials
Conflict of interest statement
Declaration of Competing Interest Monetary: FGZ has received grants for investigator-initiated trials from Ionis Pharmaceuticals (USA), Bactiguard (Sweden) and Brazilian Ministry of Health. FGZ does not own stock exchanges or received direct compensation from any company in the past 10 years. Intellectual: FGZ is involved in pragmatic critical care trials both as principal-investigator or as part of research teams. FGZ is also involved in observational studies.
Comment on
-
The effect of small versus large clog size on emergency response time: A randomized controlled trial.J Crit Care. 2020 Dec;60:116-119. doi: 10.1016/j.jcrc.2020.07.028. Epub 2020 Aug 8. J Crit Care. 2020. PMID: 32799180 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
